DHR Danaher Corporation

DHR Danaher Corporation

Healthcare · Diagnostics & Research

Desk view

Watchingmedium conviction · entry after a pullback to the $210.39 volume shelf, holds and turns back above it with RSI in the 55-65 reset band and relative volume at least 1.0x — not entered
Basis Open desk call ·Logged decision
Perspectives Biotech Capital Cycle
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bull converging

POC $224.04 · VWAP $203.12 · +12.8% vs 12m avg buyer

uptrend vol: normalchurn: quiet as of

Insiders selling 0 buy / 1 sell · Form 4, 90d $12.7M sold last open-market sell Blair Rainer

Coverage

3 watchlists

Watchlists @biotech-capital-cycle@biotech-scan@trace-glp1-manufacturing

DHR Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist DHR belongs to, members best 30-day change first — DHR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@trace-glp1-manufacturing
View watchlist →
DHR+9.9% -1.1%1d +4.2%7d TMO+6.4% -0.9%1d +4.9%7d WST+6.1% +0.3%1d +4.9%7d STE+6.1% -0.7%1d +3.9%7d BDX+5.4% -1.0%1d +4.3%7d WAT+4.4% -1.6%1d +0.7%7d STVN-16.1% -1.8%1d -2.6%7d
@biotech-capital-cycle
View watchlist →
NAUT+111.9% -4.6%1d -8.4%7d QSI+53.4% -14.5%1d -26.8%7d DNA+45.5% -12.7%1d -21.0%7d PACB+29.1% -11.7%1d -25.8%7d MTD+17.7% -1.0%1d +4.7%7d CERT+15.3% -3.0%1d +2.6%7d ILMN+14.7% -2.0%1d -5.6%7d FTRE+12.6% -1.1%1d +7.9%7d A+12.5% -1.5%1d +1.4%7d DHR+9.9% -1.1%1d +4.2%7d CRL+9.8% -2.0%1d -0.5%7d RXRX+8.8% -16.6%1d -20.4%7d SEER+6.8% -0.5%1d -7.3%7d TMO+6.4% -0.9%1d +4.9%7d AVTR+5.2% +2.0%1d +4.8%7d RVTY+4.7% -1.3%1d -1.0%7d WAT+4.4% -1.6%1d +0.7%7d ABSI+2.6% -7.1%1d -18.8%7d RGEN+1.4% -4.8%1d +0.9%7d ABCL+1.1% -6.9%1d -6.0%7d MEDP+0.3% -1.6%1d +1.1%7d IQV-0.7% -1.5%1d +2.7%7d QTRX-1.4% -6.5%1d -12.5%7d ICLR-2.2% -2.8%1d +3.7%7d TXG-3.9% -3.5%1d -13.4%7d AGIO-5.0% -3.1%1d -1.5%7d SDGR-5.6% -11.3%1d -17.2%7d XBI-6.4% -3.6%1d -6.2%7d TWST-7.2% -8.1%1d -16.9%7d CDXS-7.5% -8.8%1d -12.1%7d TEM-7.5% -9.0%1d -8.8%7d BRKR-9.7% -3.1%1d -6.9%7d LAB-11.3% -4.5%1d -8.8%7d ALMR-14.0% -7.8%1d 0.0%7d VKTX-14.7% -8.0%1d -11.7%7d GENB-22.9% -7.4%1d -15.7%7d
@biotech-scan
View watchlist →
GRAL+56.9% -13.0%1d -16.2%7d MRNA+49.7% -7.8%1d -3.1%7d DNA+45.5% -12.7%1d -21.0%7d AMGN+14.9% -0.3%1d +4.3%7d ILMN+14.7% -2.0%1d -5.6%7d RARE+12.9% -4.2%1d -6.1%7d A+12.5% -1.5%1d +1.4%7d ISRGE+11.6% -0.3%1d +0.7%7d LLY+10.5% +0.4%1d +6.6%7d DHR+9.9% -1.1%1d +4.2%7d RXRX+8.8% -16.6%1d -20.4%7d ABBV+8.7% +0.7%1d +3.2%7d LEGN+8.7% -6.7%1d -0.8%7d BIIB+7.7% -1.1%1d +3.1%7d TMO+6.4% -0.9%1d +4.9%7d GILD+5.8% -0.8%1d +3.3%7d MDT+2.3% -0.7%1d +7.1%7d REGN+2.1% -0.7%1d +5.9%7d BEAM+1.6% -5.1%1d -8.7%7d IBB-0.2% -2.6%1d -2.2%7d NTLA-0.6% +0.7%1d -12.6%7d IQV-0.7% -1.5%1d +2.7%7d DXCM-1.5% -1.9%1d +2.3%7d IBBQ-1.9% -2.7%1d -2.6%7d VRTX-2.6% -1.8%1d -2.0%7d ALNY-3.1% -0.9%1d -0.4%7d IONS-4.2% -2.7%1d -5.2%7d CRSP-5.7% -4.4%1d -7.8%7d XBI-6.4% -3.6%1d -6.2%7d NVO-6.9% -1.0%1d +0.5%7d BNTX-8.5% -2.8%1d -9.5%7d COGT-9.3% 0.0%1d -4.8%7d INCY-9.4% -0.2%1d +0.3%7d PTGX-9.9% -5.7%1d -10.4%7d KYMR-9.9% -3.1%1d -6.8%7d EDIT-13.3% -3.7%1d -19.0%7d SRPT-13.5% -3.9%1d -4.2%7d BMRN-15.5% -2.4%1d -0.2%7d IMVT-26.5% -2.8%1d -12.3%7d NKTR-46.9% -5.1%1d -13.1%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

May 11 sell n/a Stop loss +12.2% complete

Desk commentary

Authored analysis and challenge notes tied to DHR.

1

Next earnings DHR reports in 4 days Oct 21

Last report Jul 21

Reported the quarter ending 2026-06-26: revenue $6.26B, diluted EPS $1.23, net income $870M (SEC filing). Across the print the stock moved -10.9% (close before → first close after).

full note →

Against street estimates

How DHR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 21 · projection Oct 16

Result
Jul 21 1.841.94 GAAP ≠ +5.3%Beat
Apr 21 1.942.06 GAAP ≠ +6.5%Beat
Jan 28 2.192.23+2.0%In line
Oct 21 '25 1.721.89 GAAP ≠ +9.8%Beat
Jul 22 '25 1.641.80 GAAP ≠ +9.5%Beat
Apr 22 '25 1.641.88 GAAP ≠ +14.4%Beat
Jan 29 '25 2.162.14-1.1%In line
Oct 22 '24 1.571.71 GAAP ≠ +8.9%Beat

Recent news

Headlines about DHR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 16

DHR research tape

60 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Biotech Scan — October 16, 2026 scan Biotech Scan — October 9, 2026 scan Biotech Scan — October 2, 2026 scan Biotech Scan — September 25, 2026 scan Biotech Scan — September 23, 2026
Types
Oct 16 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNNVOIMVTIONSINCYALNYREGN +4 more
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 10 Market Signal Two Watches Retired on A Macro Day
DHRVRTMETALMTVICREVKTX
Sep 7 Market Brief Memory Leads, Software Splits
AMGNARKWAVALBANB.SWBDXBMYLULUPATH +4 more
Sep 6 Market Brief Micron Leads the Tuesday Entry Map
AMGNARKWAVALBANB.SWBDXBMYLULUPATH +4 more
Sep 5 Market Brief A War Priced as Rates
AMGNAMTARKWAUBDXBMYLULUPATH +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 2 Market Brief Three Beats, Three Selloffs, and a Hike Nobody Hedged
AMBAANFAPLEATEYYATIAVTDELLCRDO +4 more
Sep 1 Market Brief Neoclouds Break as One, Gold Breaks With Them
ACLSAIQAMLXARWATRCAUNGLNMM +4 more
Sep 1 Market Signal Gate Recomputes Gold Breaks and Three Convergence Raises
GLDUUPMSFTSKHYDHRBUFR
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 27 Market Brief A Risk-On Turn, Confirmed Three Ways
ABCLANETAPHARKKBESIYBHPNVDACRM +4 more
Aug 27 Article Congress Trade Tracker — Who Actually Beats the Index
NVDAGOOGLAMZNAAPLAVGOINTCVSTBE +4 more
Aug 26 Market Brief Concrete Bids, Compute Bleeds
ABBNYADA-USDAEVAAIPAKAMAPDCVIKSPI +4 more
Aug 25 Market Brief Biotech Goes Blue-Chip, Credit Slips Its Line
AGXAMRARKFBITXBKRBLMNPDDXPEV +4 more
Aug 25 Market Signal Credit Tell Slips Under Its Own Line — Divergence Signal
HYGTLTDHRNTLANBISSTXKRE
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Article Where Congress's traders actually agree — and where they don't
NVDAAVGOUBERMASPGIDHR
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 21 Catalyst DHR earnings
DHR
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 25 Article Where the Entries Are
GOOGLAMZNAAPLNVDAAVGOCRWDASMLALAB +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNBNTX +4 more
May 21 Desk Move DHR — mccaul-trades buy
DHR
May 13 Desk Move DHR — mccaul-trades buy
DHR
May 3 Desk Move DHR — mccaul-trades buy
DHR
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Apr 27 Reference Claude-Trader Playbook
ABBVABTADBEASANAVGOCEGCLXCOP +4 more
Apr 27 Reference Claude-Momentum Playbook
ABBVAMZNARMASANAVGOCRMCRSPCRWD +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Mar 31 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 24 Scan Biotech Scan
ABBVALNYAMGNBIIBBMRNBNTXCRSPDHR +4 more
Mar 20 Article Market Status Report
ABBVADBEAMKRAMZNARKKASAVGOCEG +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 13 Article Market Status Report
AAPLADBEAMDAMKRAMZNARKKASAVGO +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 13 Article Daily Actions
AAPLADBEAMZNARMASASMLBABNTX +4 more
Mar 12 Article Market Status Report
ADBEAMZNARKKAVGOCEGCLXCMGCRM +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 12 Update Biotech
ALNYBEAMBIIBBNTXCRSPDHRGILDLEGN +4 more
Mar 12 Article Daily Actions
ALERTAMZNARMASASANASMLBNTXBTC +4 more
Mar 11 Article Market Status Report
ADBEAFRMAMZNARKKASASANAVGOBNTX +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Mar 11 Article Daily Actions
AMZNARMASASANASMLBNTXBTCCEG +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNBNTXDHR +4 more